Cargando…

Genetic variations of the A13/A14 repeat located within the EGFR 3′ untranslated region have no oncogenic effect in patients with colorectal cancer

BACKGROUND: The EGFR 3′ untranslated region (UTR) harbors a polyadenine repeat which is polymorphic (A13/A14) and undergoes somatic deletions in microsatellite instability (MSI) colorectal cancer (CRC). These mutations could be oncogenic in colorectal tissue since they were shown to result into incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarafan-Vasseur, Nasrin, Sefrioui, David, Tougeron, David, Lamy, Aude, Blanchard, France, Le Pessot, Florence, Di Fiore, Frédéric, Michel, Pierre, Bézieau, Stéphane, Latouche, Jean-Baptiste, Frebourg, Thierry, Sesboüé, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626788/ https://www.ncbi.nlm.nih.gov/pubmed/23565769 http://dx.doi.org/10.1186/1471-2407-13-183

Ejemplares similares

EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Sesboüé, R, et al.
Publicado: (2012)

Regulatory T Lymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite-Unstable Colorectal Cancers
por: Tougeron, David, et al.
Publicado: (2013)

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010)

Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer
por: Patout, Maxime, et al.
Publicado: (2019)

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
por: Allouchery, Violette, et al.
Publicado: (2018)

Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
por: Fiore, F Di, et al.
Publicado: (2008)

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
por: Di Fiore, F, et al.
Publicado: (2007)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
por: Oden-Gangloff, A, et al.
Publicado: (2009)

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
por: Clatot, Florian, et al.
Publicado: (2016)

Impact of EGFR(A289T/V) mutation on relapse pattern in glioblastoma
por: Noeuveglise, A., et al.
Publicado: (2022)

CDK5: an oncogene or an anti-oncogene: location location location
por: Nikhil, Kumar, et al.
Publicado: (2023)

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer
por: Clatot, Florian, et al.
Publicado: (2020)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

A case of Pseudomyxoma Peritonei of an unexpected origin
por: Csanyi-Bastien, Marie, et al.
Publicado: (2021)

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022)

Conserved Usage of Alternative 5′ Untranslated Exons of the GATA4 Gene
por: Mazaud Guittot, Séverine, et al.
Publicado: (2009)

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients
por: Allouchery, Violette, et al.
Publicado: (2021)

Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations
por: Schuster, Samantha L., et al.
Publicado: (2023)

EGFR transactivates RON to drive oncogenic crosstalk
por: Franco Nitta, Carolina, et al.
Publicado: (2021)

Genetic variations regulate alternative splicing in the 5' untranslated regions of the mouse glioma-associated oncogene 1, Gli1
por: Palaniswamy, Ramesh, et al.
Publicado: (2010)

Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
por: Greulich, Heidi, et al.
Publicado: (2005)

Untranslated regions of mRNAs
por: Mignone, Flavio, et al.
Publicado: (2002)

Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022)

Systematic Identification of Oncogenic EGFR Interaction Partners
por: Petschnigg, Julia, et al.
Publicado: (2017)

EGFR(vIII): An Oncogene with Ambiguous Role
por: Rutkowska, Adrianna, et al.
Publicado: (2019)

In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions
por: Aouacheria, Abdel, et al.
Publicado: (2007)

The ODC 3′-Untranslated Region and 5′-Untranslated Region Contain cis-Regulatory Elements: Implications for Carcinogenesis
por: Nowotarski, Shannon L., et al.
Publicado: (2017)

Massively parallel functional annotation of 3' untranslated regions
por: Zhao, Wenxue, et al.
Publicado: (2014)

Properties of untranslated regions of the S. cerevisiae genome
por: Tuller, Tamir, et al.
Publicado: (2009)

Variation in the Untranslated Genome and Susceptibility to Infections
por: Ramsuran, Veron, et al.
Publicado: (2018)

The 5′-Untranslated Region of Picornaviral Genomes
por: Agol, Vadim I.
Publicado: (1991)

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

The 5′ and 3′ Untranslated Regions of the Flaviviral Genome
por: Ng, Wy Ching, et al.
Publicado: (2017)

EGFR mutations in sinonasal squamous tumors: oncogenic and therapeutic implications
por: Udager, Aaron M., et al.
Publicado: (2015)

BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
por: Costa, Daniel B, et al.
Publicado: (2007)

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2
por: Bae, Kieun, et al.
Publicado: (2022)

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)
por: Bruera, Gemma, et al.
Publicado: (2013)

Characterization of 3'-untranslated region of the mouse GDNF gene
por: Oh-hashi, Kentaro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h1qumm6ae4pifi9vj2r4bgn3lp